FDA Inspection
Comparative Biosciences, IncComparative Biosciences, Inc – FDA Inspection, May 17, 2019
Record Details
This FDA Inspection record concerns Comparative Biosciences, Inc, with an inspection on May 17, 2019, issued by the San Francisco District Office, covering human drugs.
- Person
- Dustin P. Tran (Issuing Officer)
View Company Profile
ID · 999e6681-ca7c-4b4b-adab-84dbbf37faab
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1089886
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 58.105(c)Test article: storage container labeling
- 21 CFR 58.83Reagents: labeling
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Comparative Biosciences, Inc
2| Date | Classification | Office | Project area |
|---|---|---|---|
| April 10, 2026 | Not classified | San Francisco District Office | Bioresearch Monitoring |
| July 30, 2024 | VAI | San Francisco District Office | Bioresearch Monitoring |
Other documents for Comparative Biosciences, Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.